$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2023 Q1 Form 10-Q Financial Statement

#000164033423000043 Filed on January 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q3 2021 Q3
Revenue $25.20K $25.39K $41.84K
YoY Change 19.06% -39.3% 185.36%
Cost Of Revenue $24.85K $9.700K $40.63K
YoY Change -76.13% 72.53%
Gross Profit $350.00 $15.69K $1.209K
YoY Change -98.35% 1198.01% -113.6%
Gross Profit Margin 1.39% 61.8% 2.89%
Selling, General & Admin $60.70K $73.73K $83.78K
YoY Change -24.89% -12.0% 13.26%
% of Gross Profit 17342.86% 469.83% 6929.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $60.70K $73.73K $83.78K
YoY Change -24.89% -12.0% 13.26%
Operating Profit -$60.35K -$58.04K -$82.57K
YoY Change 1.18% -29.72% -0.35%
Interest Expense -$11.77K $76.31K -$4.524M
YoY Change -110.46% -101.69% 5446.38%
% of Operating Profit
Other Income/Expense, Net -$11.77K -$613.2K -$4.524M
YoY Change -101.36% -86.44% 5446.25%
Pretax Income -$72.13K -$671.3K -$4.606M
YoY Change -108.97% -85.43% 2701.32%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$72.13K -$671.3K -$4.606M
YoY Change -108.97% -85.43% 2701.4%
Net Earnings / Revenue -286.23% -2643.56% -11009.89%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.712B shares
Diluted Shares Outstanding 11.26B shares 9.821B shares 8.981B shares

Balance Sheet

Concept 2023 Q1 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $810.00 $12.59K $66.13K
YoY Change -94.53% -80.96% 8270.89%
Cash & Equivalents $810.00 $12.59K $66.13K
Short-Term Investments
Other Short-Term Assets $7.500K
YoY Change
Inventory
Prepaid Expenses $7.500K
Receivables
Other Receivables
Total Short-Term Assets $810.00 $20.09K $66.13K
YoY Change -96.37% -69.63% 8270.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $4.00 $1.00
YoY Change -100.0% 300.0%
TOTAL ASSETS
Total Short-Term Assets $810.00 $20.09K $66.13K
Total Long-Term Assets $0.00 $4.00 $1.00
Total Assets $810.00 $20.09K $66.13K
YoY Change -96.37% -69.62% 8270.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $605.9K $46.52K $446.2K
YoY Change 25.54% -89.57% 1022.44%
Accrued Expenses $497.1K $388.6K $202.6K
YoY Change 75.93% 91.84% -55.78%
Deferred Revenue
YoY Change
Short-Term Debt $967.1K $900.5K $701.8K
YoY Change 12.25% 28.31% -11.51%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.978M $5.746M $15.35M
YoY Change -17.28% -62.58% 365.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.978M $5.746M $15.35M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.978M $5.746M $15.35M
YoY Change -17.28% -62.58% 365.93%
SHAREHOLDERS EQUITY
Retained Earnings -$10.65M -$19.70M
YoY Change -45.94%
Common Stock $3.535M $3.291M
YoY Change 7.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.977M -$5.726M -$15.29M
YoY Change
Total Liabilities & Shareholders Equity $810.00 $20.09K $66.13K
YoY Change -96.37% -69.63% 8270.76%

Cashflow Statement

Concept 2023 Q1 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$72.13K -$671.3K -$4.606M
YoY Change -108.97% -85.43% 2701.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$35.10K -$13.09K -$53.42K
YoY Change 78.32% -75.5% 108.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.90K 0.000 -10.00K
YoY Change -100.0% -1100.0%
NET CHANGE
Cash From Operating Activities -35.10K -13.09K -53.42K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 25.90K 0.000 -10.00K
Net Change In Cash -9.200K -13.09K -63.42K
YoY Change -53.26% -79.36% 157.49%
FREE CASH FLOW
Cash From Operating Activities -$35.10K -$13.09K -$53.42K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
34481 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
522668 usd
CY2022Q3 boty Promissory Notes Payable Current
PromissoryNotesPayableCurrent
331968 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
us-gaap Revenues
Revenues
78831 usd
us-gaap Revenues
Revenues
76339 usd
CY2022Q3 boty Cost Of Service
CostOfService
9700 usd
CY2021Q3 boty Cost Of Service
CostOfService
40628 usd
boty Cost Of Service
CostOfService
24657 usd
boty Cost Of Service
CostOfService
66660 usd
us-gaap Gross Profit
GrossProfit
54174 usd
us-gaap Gross Profit
GrossProfit
9679 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61240 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99536 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
73728 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
83782 usd
us-gaap Operating Expenses
OperatingExpenses
204240 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-58035 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-82573 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-150066 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-206807 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
76307 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
174984 usd
us-gaap Interest Expense
InterestExpense
257415 usd
us-gaap Interest Expense
InterestExpense
470641 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-536936 usd
CY2021Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-4348651 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1480510 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-613243 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4523635 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1223095 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11291887 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-671278 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4606208 usd
us-gaap Net Income Loss
NetIncomeLoss
1073029 usd
us-gaap Net Income Loss
NetIncomeLoss
-11498694 usd
CY2022Q3 boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
-0.00
CY2021Q3 boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
-0.00
boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
0.00
boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding1
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding1
3535302536 shares
CY2021Q3 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding1
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding1
3318713236 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding1
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding1
3535302536 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding1
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding1
2844080980 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9821423487 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8980638462 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9821423487 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8506006206 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6798809 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-671278 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-11728241 usd
CY2021Q3 boty Shares Of Common Stock Issued For Conversion Of Debts And Accrued Interest Amount
SharesOfCommonStockIssuedForConversionOfDebtsAndAccruedInterestAmount
164991 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001407704
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
32482 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3535302536 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3535302536 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3535302536 shares
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55498
dei Entity Registrant Name
EntityRegistrantName
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8009362
dei Entity Address Address Line1
EntityAddressAddressLine1
6955 North Durango Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1115-129
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89149
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
505-0743
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3711714036 shares
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
12586 usd
CY2022Q3 boty Professional Fee
ProfessionalFee
21000 usd
CY2021Q3 boty Professional Fee
ProfessionalFee
9900 usd
boty Professional Fee
ProfessionalFee
53000 usd
boty Professional Fee
ProfessionalFee
26950 usd
us-gaap Operating Expenses
OperatingExpenses
216486 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-10821246 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5994823 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
940322 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5054501 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5878867 usd
CY2021Q1 boty Shares Of Common Stock Issued For Conversion Of Debts And Accrued Interest Amount
SharesOfCommonStockIssuedForConversionOfDebtsAndAccruedInterestAmount
9571 usd
CY2021Q1 boty Shares Of Common Stock Issued For Exercise Of Warrants Amount
SharesOfCommonStockIssuedForExerciseOfWarrantsAmount
0 usd
CY2021Q1 boty Write Off Of Convertible Notes And Accrued Interest
WriteOffOfConvertibleNotesAndAccruedInterest
110076 usd
CY2021Q1 boty Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off
DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff
346640 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7547040 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-12959620 usd
CY2021Q2 boty Shares Of Common Stock Issued For Conversion Of Debts And Accrued Interest Amount
SharesOfCommonStockIssuedForConversionOfDebtsAndAccruedInterestAmount
102245 usd
CY2021Q2 boty Shares Of Common Stock Issued For Exercise Of Warrants Amount
SharesOfCommonStockIssuedForExerciseOfWarrantsAmount
0 usd
CY2021Q2 boty Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off
DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff
474581 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
654554 usd
CY2021Q3 boty Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off
DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff
882527 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4606208 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15286931 usd
us-gaap Profit Loss
ProfitLoss
1073029 usd
us-gaap Profit Loss
ProfitLoss
-11498694 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-1480510 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
10821246 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
100669 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
359479 usd
boty Note Conversion Fee
NoteConversionFee
0 usd
boty Note Conversion Fee
NoteConversionFee
1500 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
57500 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
57500 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25671 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-55207 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
156746 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
111163 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66895 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-203013 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
45000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
265000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
265000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-21895 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
61987 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34481 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4142 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12586 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66129 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
52000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
265000 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1703748 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
276806 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
267439 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
110076 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lingerie Fighting Championships, Inc. (the “Company”) is a Nevada corporation incorporated on November 29, 2006 under the name Sparking Events, Inc. The Company’s corporate name was changed to Xodtec Group USA, Inc. in June 2009, Xodtec LED, Inc. in May 2010, Cala Energy Corp. in September 2013 and Lingerie Fighting Championships, Inc. on April 1, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company focuses on developing, producing, promoting, and distributing entertainment through live entertainment events, digital home videos, broadcast television networks, video on demand, and digital media channels in the United States. It offers wrestling and mixed martial arts fights featuring women under the LFC brand name.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior period amounts have been reclassified to conform with the current year presentation.</p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12586 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34481 usd
us-gaap Revenues
Revenues
76339 usd
us-gaap Cost Of Revenue
CostOfRevenue
24657 usd
us-gaap Cost Of Revenue
CostOfRevenue
66660 usd
us-gaap Gross Profit
GrossProfit
54174 usd
us-gaap Gross Profit
GrossProfit
9679 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6286120951 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5661925226 shares
boty Related Party Balances And Transactionspolicytextblock
RelatedPartyBalancesAndTransactionspolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows FASB ASC 850, “<em>Related Party Disclosures</em>,” for the identification of related parties and disclosure of related party transaction. (See Note 9)</p>
CY2022Q3 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
3887597 usd
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5323107 usd
CY2021Q1 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
300000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3535302536 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5438166666 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2021 boty Number Of Shares Granted
NumberOfSharesGranted
400000000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0002
CY2021 boty Redeemed Per Share
RedeemedPerShare
0
CY2021 boty Exercised
Exercised
-281500000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0003
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5556666666 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
boty Number Of Shares Granted
NumberOfSharesGranted
208000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0005
boty Redeemed Per Share
RedeemedPerShare
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5764666666 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2021Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
248077 usd
CY2021Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 usd
CY2021Q4 boty Warrants Derivative Amount
WarrantsDerivativeAmount
31000 usd
CY2021Q4 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
40000 usd
us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
0.0001
boty Expected Term
ExpectedTerm
P3Y1M6D
boty Expected Term
ExpectedTerm
P4Y3M10D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2111333 usd
CY2022Q3 boty Closing Market Price
ClosingMarketPrice
0.0005
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5764666666 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5556666666 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2864582 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4444017 shares
boty Schedule Of Promissory Notes Payable
ScheduleOfPromissoryNotesPayable
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Promissory Notes to Auctus Fund</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less Debt Discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(8,032</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(89,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Promissory Notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">331,968</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">250,817</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3 boty Promissory Notes To Auctus Fund
PromissoryNotesToAuctusFund
340000 usd
CY2021Q4 boty Promissory Notes To Auctus Fund
PromissoryNotesToAuctusFund
340000 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8032 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
89183 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
331968 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
250817 usd
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
35000 usd
CY2021Q1 boty Warrants Derivative Amount
WarrantsDerivativeAmount
265000 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2740 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5323107 usd
boty Addition Of New Derivative Liabilities Upon Issuance Of Convertible Notes As Debt Discount
AdditionOfNewDerivativeLiabilitiesUponIssuanceOfConvertibleNotesAsDebtDiscount
-34340 usd
boty Addition Of New Derivative Liabilities Upon Issuance Of Warrants As Debt Discount
AdditionOfNewDerivativeLiabilitiesUponIssuanceOfWarrantsAsDebtDiscount
79340 usd
boty Addition Of New Derivatives Liabilities Recognized As Day One Loss On Warrants
AdditionOfNewDerivativesLiabilitiesRecognizedAsDayOneLossOnWarrants
72101 usd
boty Gain On Change In Fair Value Of The Derivative
GainOnChangeInFairValueOfTheDerivative
-1552611 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
3887597 usd
boty Loss Due To Derivative Liabilities On Warrants
LossDueToDerivativeLiabilitiesOnWarrants
72101 usd
boty Loss Due To Derivative Liabilities On Warrants
LossDueToDerivativeLiabilitiesOnWarrants
346970 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-1552611 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
10474276 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1480510 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
10821246 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y7M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M9D
CY2022Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
522668 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
465168 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176411500 shares
CY2022Q4 boty Common Stock Exercise
CommonStockExercise
201613143 shares

Files In Submission

Name View Source Status
0001640334-23-000043-index-headers.html Edgar Link pending
0001640334-23-000043-index.html Edgar Link pending
0001640334-23-000043.txt Edgar Link pending
0001640334-23-000043-xbrl.zip Edgar Link pending
boty-20220930.xsd Edgar Link pending
boty-20220930_cal.xml Edgar Link unprocessable
R37.htm Edgar Link pending
boty_10q.htm Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
boty-20220930_pre.xml Edgar Link unprocessable
boty-20220930_lab.xml Edgar Link unprocessable
boty-20220930_def.xml Edgar Link unprocessable
boty_10q_htm.xml Edgar Link completed